Terms: = Germ cell tumor AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476
106 results:
1. Recurrence Patterns and Surveillance Imaging in Pediatric Brain tumor Survivors.
Cacciotti C; Lenzen A; Self C; Pillay-Smiley N
J Pediatr Hematol Oncol; 2024 Apr; 46(3):e227-e232. PubMed ID: 38447113
[TBL] [Abstract] [Full Text] [Related]
2. A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma.
Wang H; Yan L; Liu L; Lu X; Chen Y; Zhang Q; Chen M; Cai L; Dai Z
PeerJ; 2023; 11():e16412. PubMed ID: 38025749
[TBL] [Abstract] [Full Text] [Related]
3. Adrenalectomy approach and outcomes according to surgeon volume.
Ginzberg SP; Gasior JA; Kelz LR; Passman JE; Soegaard Ballester JM; Roses RE; Fraker DL; Wachtel H
Am J Surg; 2024 Mar; 229():44-49. PubMed ID: 37940441
[TBL] [Abstract] [Full Text] [Related]
4. Exploring the anti-glioma mechanism of the active components of Cortex Periplocae based on network pharmacology and iTRAQ proteomics in vitro.
Huan J; You CP; Lu YC; Che FY
Adv Clin Exp Med; 2023 Nov; 32(11):1279-1290. PubMed ID: 37901992
[TBL] [Abstract] [Full Text] [Related]
5. Automated Brain tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
Gutsche R; Lowis C; Ziemons K; Kocher M; Ceccon G; Régio Brambilla C; Shah NJ; Langen KJ; Galldiks N; Isensee F; Lohmann P
J Nucl Med; 2023 Oct; 64(10):1594-1602. PubMed ID: 37562802
[TBL] [Abstract] [Full Text] [Related]
6. Pediatric Optic Pathway Gliomas Resource Utilization and Prevalence in the OptumLabs Data Warehouse.
Stoddard-Bennett TN; Yu F; Spiegel SJ; Perez CF; Coleman AL; Repka MX; Pineles SL
J Neuroophthalmol; 2024 Mar; 44(1):10-15. PubMed ID: 37505911
[TBL] [Abstract] [Full Text] [Related]
7. A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors.
Godlewski A; Czajkowski M; Mojsak P; Pienkowski T; Gosk W; Lyson T; Mariak Z; Reszec J; Kondraciuk M; Kaminski K; Kretowski M; Moniuszko M; Kretowski A; Ciborowski M
Sci Rep; 2023 Jul; 13(1):11044. PubMed ID: 37422554
[TBL] [Abstract] [Full Text] [Related]
8. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
Ye L; Tong S; Wang Y; Wang Y; Ma W
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
[TBL] [Abstract] [Full Text] [Related]
9. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract] [Full Text] [Related]
10. Correlations between intravoxel incoherent motion-derived fast diffusion and perfusion fraction parameters and VEGF- and MIB-1-positive rates in brain gliomas: an intraoperative MR-navigated, biopsy-based histopathologic study.
Sheng Y; Dang X; Zhang H; Rui W; Wang J; Cheng H; Qiu T; Zhang Y; Ding Y; Yao Z; Pang H; Ren Y
Eur Radiol; 2023 Aug; 33(8):5236-5246. PubMed ID: 36941492
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic tumors.
Jeremie G; Allias F; Trecourt A; Gaillot-Durand L; Bolze PA; Descotes F; Tondeur G; Perrot J; Hajri T; You B; Golfier F; Lopez J; Devouassoux-Shisheboran M
Mod Pathol; 2023 Jan; 36(1):100046. PubMed ID: 36788063
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review.
Ward R; Jones HM; Witt D; Boop F; Bouffet E; Rodriguez-Galindo C; Qaddoumi I; Moreira DC
JCO Glob Oncol; 2022 Oct; 8():e2200199. PubMed ID: 36198134
[TBL] [Abstract] [Full Text] [Related]
13. The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression.
Kim CM; Lee JB; Shin SJ; Ahn JB; Lee M; Kim HS
ESMO Open; 2022 Oct; 7(5):100577. PubMed ID: 36156450
[TBL] [Abstract] [Full Text] [Related]
14. Multiple primary melanoma in association with other personal and familial cancers.
Yang X; Karapetyan L; Huang Z; Knight AD; Rajendran S; Sander C; Minnier CP; Wilson MJ; Kirkwood JM
Cancer Med; 2023 Feb; 12(3):2474-2483. PubMed ID: 35932099
[TBL] [Abstract] [Full Text] [Related]
15. Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.
Tew A; Khoja L; Pallan L; Steven N
J Oncol Pharm Pract; 2023 Jul; 29(5):1163-1171. PubMed ID: 35607278
[TBL] [Abstract] [Full Text] [Related]
16. Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine tumors.
Shannon AB; Straker RJ; Fraker DL; Miura JT; Karakousis GC
J Am Coll Surg; 2022 May; 234(5):900-909. PubMed ID: 35426404
[TBL] [Abstract] [Full Text] [Related]
17. Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.
Adamson AS; Suarez EA; Welch HG
JAMA Dermatol; 2022 Apr; 158(4):426-431. PubMed ID: 35293957
[TBL] [Abstract] [Full Text] [Related]
18. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.
Engelhardt S; Behling F; Beschorner R; Eckert F; Kohlhof P; Tatagiba M; Tabatabai G; Schuhmann MU; Ebinger M; Schittenhelm J
J Cancer Res Clin Oncol; 2022 Apr; 148(4):857-866. PubMed ID: 35018490
[TBL] [Abstract] [Full Text] [Related]
19. Trends in incidence and survival of patients with vulvar cancer in an Asian country: Analysis of the Korean Central Cancer Registry 1999-2018.
Shin DW; Bae J; Ha J; Lee WM; Jung KW
Gynecol Oncol; 2022 Feb; 164(2):386-392. PubMed ID: 34893346
[TBL] [Abstract] [Full Text] [Related]
20. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Liu APY; Smith KS; Kumar R; Paul L; Bihannic L; Lin T; Maass KK; Pajtler KW; Chintagumpala M; Su JM; Bouffet E; Fisher MJ; Gururangan S; Cohn R; Hassall T; Hansford JR; Klimo P; Boop FA; Stewart CF; Harreld JH; Merchant TE; Tatevossian RG; Neale G; Lear M; Klco JM; Orr BA; Ellison DW; Gilbertson RJ; Onar-Thomas A; Gajjar A; Robinson GW; Northcott PA
Cancer Cell; 2021 Nov; 39(11):1519-1530.e4. PubMed ID: 34678152
[TBL] [Abstract] [Full Text] [Related]
[Next]
